New York City-based Weill Cornell has established a cancer research collaborative to explore ways to improve the effectiveness of immunotherapy through nutrition, metabolism and emerging therapeutics.
The Weill Cancer Hub East will connect leaders from Weill Cornell Medicine, Princeton (N.J.) University, New York City-based Rockefeller University and the Ludwig Institute for Cancer Research, also in New York City, according to a March 27 news release from Weill Cornell.
An initial $50 million gift from the Weill Family Foundation to establish the research hub will be matched by the philanthropic efforts of each partner institution, totaling more than $125 million.
“The initiative seeks to break down institutional barriers and unite top experts in cancer biology, cancer clinical trials, immunology, nutrition and metabolism to drive pioneering, cross-field collaboration that pushes the boundaries of scientific discovery,” the release said.
